SB-659032 Platelet Aggregation Study

A Study With Darapladib to Collect Tolerability Information

NCT00704431 ·Status: COMPLETED ·Phase: PHASE1

Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)

NCT03297814 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese Men

NCT00551317 ·Status: COMPLETED ·Phase: PHASE1

Comparison Of Two Tablet Formulations Of SB-568859

NCT00470145 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis

NCT00382213 ·Status: COMPLETED ·Phase: PHASE3

Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-

NCT00622830 ·Status: COMPLETED ·Phase: PHASE1

The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

NCT05009862 ·Status: COMPLETED ·Phase: PHASE4

Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?

NCT02983214 ·Status: COMPLETED ·Phase: PHASE4

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

NCT00799903 ·Status: COMPLETED ·Phase: PHASE3

Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease

NCT02388971 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of Pactimibe in Patients With Atherosclerosis

NCT00185146 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

NCT07303777 ·Status: RECRUITING ·Phase: PHASE2

Effects of Rivaroxaban on Vascular FMD in Patients With Stable Atherosclerotic Vascular Diseases

NCT06986369 ·Status: COMPLETED ·Phase: PHASE4

GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound

NCT01813422 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects

NCT01873339 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease

NCT02393612 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment

NCT01711723 ·Status: COMPLETED ·Phase: PHASE1

Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients

NCT00995930 ·Status: COMPLETED ·Phase: PHASE2

Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848).

NCT01852565 ·Status: COMPLETED ·Phase: PHASE1

Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans

NCT01067339 ·Status: COMPLETED ·Phase: PHASE3

A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack

NCT07301034 ·Status: RECRUITING ·Phase: PHASE3

Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events

NCT05537571 ·Status: COMPLETED ·Phase: PHASE2

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

NCT07157774 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging

NCT00633022 ·Status: COMPLETED ·Phase: PHASE2

A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients

NCT01499420 ·Status: COMPLETED ·Phase: PHASE2